Alterations in the Intraocular Cytokine Milieu after Intravitreal Bevacizumab | Zendy

Farzin Forooghian | Zendy; Peter J. Kertes | Zendy; Kenneth T. Eng | Zendy; Elvira Agrón | Zendy; Emily Y. Chew | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Alterations in the Intraocular Cytokine Milieu after Intravitreal Bevacizumab

Author(s) -

Farzin Forooghian,

Peter J. Kertes,

Kenneth T. Eng,

Elvira Agrón,

Emily Y. Chew

Publication year - 2010

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.09-4065

Subject(s) - bevacizumab , medicine , cytokine , pars plana , vitrectomy , ophthalmology , vascular endothelial growth factor , diabetic retinopathy , proliferative vitreoretinopathy , retinal , retinal detachment , endocrinology , vegf receptors , visual acuity , chemotherapy , diabetes mellitus

Several complications after intravitreal bevacizumab (IVB) treatment have been described including tears of the retinal pigment epithelium and tractional retinal detachment. The etiology of these complications remains unclear. The purpose of this study was to characterize changes in the intraocular levels of inflammatory cytokines after IVB as a possible explanation for these complications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research